Men (n = 3513) | Women (n = 2467) | OR* adjusted for age (95% CI) | |
Left ventricular systolic dysfunction (n) | 2490 | 1094 | |
Mean age (SD) | 65.7 (12.4) | 71.1 (12.6) | |
History of hypertension (%) | 1179 (47) | 628 (57) | 1.50 (1.30 to 1.73) |
Myocardial infarction, ever (%) | 1383 (56) | 528 (48) | 0.67 (0.58 to 0.78) |
History of angina (%) | 1191 (48) | 500 (46) | 0.85 (0.74 to 0.99) |
Revascularisation (PCI, CABG) (%) | 687 (28) | 175 (16) | 0.53 (0.44 to 0.63) |
Cumulative evidence for CAD† (%) | 1754 (70) | 720 (66) | 0.68 (0.58 to 0.80) |
Preserved left ventricular function (n) | 1023 | 1373 | |
Mean age (SD) | 68.3 (12.6) | 72.9 (11.6) | |
History of hypertension (%) | 559 (55) | 880 (64) | 1.42 (1.20 to 1.67) |
Myocardial infarction, ever (%) | 377 (37) | 311 (23) | 0.49 (0.41 to 0.59) |
History of angina (%) | 499 (48) | 547 (40) | 0.69 (0.58 to 0.81) |
Revascularisation (PCI, CABG) (%) | 238 (23) | 146 (11) | 0.42 (0.34 to 0.53) |
Cumulative evidence for CAD† (%) | 656 (64) | 726 (53) | 0.61 (0.51 to 0.72) |
*OR >1 correlates with a higher prevalence in women.
†CAD (coronary artery disease): myocardial infarction, angina, or revascularisation.
PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting.